Creon 40,000

pancrelipase · Abbott Products

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Creon 40,000, covering 2011-08-18 to 2011-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis [Phase 3]